Ramsland Paul A, Farrugia William
Structural Biology Laboratory, The Austin Research Institute, Studley Road, Heidelberg, Victoria 3084, Australia.
J Mol Recognit. 2002 Sep-Oct;15(5):248-59. doi: 10.1002/jmr.585.
Sequencing of all human immunoglobulin (Ig) germline gene segments has recently been completed. However, our first glimpses of the recombined products of this combinatorial gene system were in the 1970s, in landmark publications, reporting the crystal structures of two human myeloma proteins, the Mcg lambda light chain dimer and the New IgG1(lambda) Fab. Although numerous crystal structures of murine and human antibodies have now been determined, only a relatively small proportion of the human germline genes have had their corresponding protein three-dimensional structures resolved. Therefore, further structural investigations are required before the inherent diversity of the antibody repertoire can be fully appreciated. We discuss the detailed structural information available for human antibodies with regard to their immune functions. Also discussed, is how the structural information is finding application in the 'humanization' of murine antibodies as part of their development as 'biopharmaceuticals' for the treatment of human disease.
所有人类免疫球蛋白(Ig)种系基因片段的测序工作最近已经完成。然而,我们对这个组合基因系统重组产物的首次了解是在20世纪70年代,在具有里程碑意义的出版物中,报道了两种人类骨髓瘤蛋白的晶体结构,即Mcg λ轻链二聚体和New IgG1(λ) Fab。尽管现在已经确定了许多小鼠和人类抗体的晶体结构,但只有相对较小比例的人类种系基因的相应蛋白质三维结构得到了解析。因此,在能够充分认识抗体库的内在多样性之前,还需要进一步的结构研究。我们讨论了关于人类抗体免疫功能的详细结构信息。还讨论了结构信息如何在鼠源抗体“人源化”中得到应用,这是它们作为治疗人类疾病的“生物药物”开发的一部分。